For help on how to get the results you want, see our search tips.
240 results
Medicine
Referrals Remove Referrals filter
Referral status
European Commission final decision Remove European Commission final decision filter
Under evaluation Remove Under evaluation filter
Referral type
Article 36 referrals (prior to July 2012) Remove Article 36 referrals (prior to July 2012) filter
Article 30 referrals Remove Article 30 referrals filter
Article 6(12) referrals (prior to January 2010) Remove Article 6(12) referrals (prior to January 2010) filter
Article 29(4) referrals Remove Article 29(4) referrals filter
-
List item
Referral: Cozaar Comp
losartan + hydrochlorothiazide, Article 30 referrals
Status: European Commission final decision, opinion/position date: 24/04/2008, EC decision date: 03/09/2008, Last updated: 25/09/2008 -
List item
Referral: Actilyse
Alteplase, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 27/06/2002, EC decision date: 30/09/2002, Last updated: 25/01/2006 -
List item
Referral: Actira
moxifloxacin, Article 6(12) referrals (prior to January 2010)
Status: European Commission final decision, opinion/position date: 20/03/2008, EC decision date: 14/07/2008, Last updated: 13/10/2008 -
List item
Referral: Adartrel
Ropinirole, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 15/09/2005, EC decision date: 03/04/2006, Last updated: 21/04/2006 -
List item
Referral: Aggrastat
Tirofiban, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 26/03/1999, EC decision date: 18/06/1999, Last updated: 18/06/1999 -
List item
Referral: Agopton
Lansoprazole, Article 30 referrals
Status: European Commission final decision, opinion/position date: 21/09/2006, EC decision date: 13/12/2006, Last updated: 20/12/2006 -
List item
Referral: Alcover and associated names
sodium oxybate, associated names: n/a, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 26/01/2017, EC decision date: 18/12/2017, Last updated: 12/01/2018 -
List item
Referral: Alendronate HEXAL
alendronic acid (as sodium alendronate trihydrate), Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 25/01/2007, EC decision date: 13/04/2007, Last updated: 20/08/2007 -
List item
Referral: Alvesco
ciclesonide, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 20/03/2008, EC decision date: 11/07/2008, Last updated: 05/08/2008 -
List item
Referral: Amaryl
Glimepiride, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 17/04/1996, EC decision date: 29/08/1996, Last updated: 03/08/1998 -
List item
Referral: Amlodipin Woerwag
Amlodipine, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 21/01/2004, EC decision date: 27/04/2004, Last updated: 30/06/2004 -
List item
Referral: Amlovita
Amlodipine, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 21/01/2004, EC decision date: 26/04/2004, Last updated: 26/04/2004 -
List item
Referral: Amoxil
amoxicillin, Article 30 referrals
Status: European Commission final decision, opinion/position date: 25/06/2015, EC decision date: 20/08/2015, Last updated: 19/05/2016 -
List item
Referral: Arcoxia
etoricoxib, Article 6(12) referrals (prior to January 2010)
Status: European Commission final decision, opinion/position date: 26/06/2008, EC decision date: 09/09/2008, Last updated: 21/11/2008 -
List item
Referral: Arimidex
anastrozole, Article 30 referrals
Status: European Commission final decision, opinion/position date: 17/03/2011, EC decision date: 18/05/2011, Last updated: 27/07/2011 -
List item
Referral: Atacand
candesartan, associated names: Amias, Blopress, Kenzen, Racanda, Ratacand, Parapres, Article 30 referrals
Status: European Commission final decision, opinion/position date: 18/03/2010, EC decision date: 13/07/2010, Last updated: 16/03/2011 -
List item
Referral: Atacand Plus
candesartan / hydrochlorothiazide, associated names: Atacand Zid, Blopresid, Blopress Comp, Blopress Plus, CoKenzen, Hytacand, Parapres Plus, Ratacand Plus, Article 30 referrals
Status: European Commission final decision, opinion/position date: 24/06/2010, EC decision date: 16/09/2010, Last updated: 21/09/2011 -
List item
Referral: Augmentin
amoxicillin and clavulanic acid, Article 30 referrals
Status: European Commission final decision, opinion/position date: 19/01/2009, EC decision date: 19/10/2009, Last updated: 18/11/2013 -
List item
Referral: Avalox
moxifloxacin, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 25/06/2009, EC decision date: 02/10/2009, Last updated: 19/11/2013 -
List item
Referral: Avelox
moxifloxacin, Article 6(12) referrals (prior to January 2010)
Status: European Commission final decision, opinion/position date: 20/03/2008, EC decision date: 14/07/2008, Last updated: 13/10/2008 -
List item
Referral: Betavert N
betahistine dihydrochloride, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 20/03/2009, EC decision date: 02/06/2009, Last updated: 01/07/2007 -
List item
Referral: Bicaluplex
bicalutamide, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 20/09/2007, EC decision date: 22/11/2007, Last updated: 07/02/2008 -
List item
Referral: Bifril, Teoula, Zofepril, Zopranol
zofenopril, Article 6(12) referrals (prior to January 2010)
Status: European Commission final decision, opinion/position date: 27/07/2000, EC decision date: 29/11/2000, Last updated: 29/11/2000 -
List item
Referral: Bleomycin
bleomycin, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 19/12/2008, EC decision date: 12/03/2009, Last updated: 31/03/2009 -
List item
Referral: Budesonide Sandoz
budesonide, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 20/02/2009, EC decision date: 07/05/2009, Last updated: 25/06/2009